Authors: Thompson, LA Tebben, AJ

Citation: La. Thompson et Aj. Tebben, Chapter 24. Pharmacokinetics and design of aspartyl protease inhibitors, ANNU REP M, 36, 2001, pp. 247-256

Authors: Carter, PH Scherle, PA Muckelbauer, JA Voss, ME Liu, RQ Thompson, LA Tebben, AJ Solomon, KA Lo, YC Li, Z Strzemienski, P Yang, GJ Falahatpisheh, N Xu, M Wu, ZR Farrow, NA Ramnarayan, K Wang, J Rideout, D Yalamoori, V Domaille, P Underwood, DJ Trzaskos, JM Friedman, SM Newton, RC Decicco, CP

Citation: Ph. Carter et al., Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha, P NAS US, 98(21), 2001, pp. 11879-11884

Authors: Kendall, RL Rutledge, RZ Mao, X Tebben, AJ Hungate, RW Thomas, KA

Citation: Rl. Kendall et al., Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues, J BIOL CHEM, 274(10), 1999, pp. 6453-6460

Authors: Lynch, JJ Houle, MS Stump, GL Wallace, AA Gilberto, DB Jahansouz, H Smith, GR Tebben, AJ Liverton, NJ Selnick, HG Claremon, DA Billman, GE

Citation: Jj. Lynch et al., Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I-Ks, in canine models of malignant ischemic ventricular arrhythmia, CIRCULATION, 100(18), 1999, pp. 1917-1922